Efficacy of Magnesium Sulfate Bolus in Pediatric Patients With Bronchiolitis

• Status: Not yet recruiting
• Trial end date: 2024-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to more rigorously evaluate the response to a single bolus of magnesium sulfate in a population of patients with moderate to severe bronchiolitis. The primary outcome will be to evaluate the effect of this therapy on clinical respiratory status. Secondary outcomes of interest will include the incidence of adverse effects and safety profile of magnesium bolus use in this population.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Louisville
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Infants under 12 months of age

• Admitted to the pediatric intensive care unit

• Moderate/severe bronchiolitis using MPIS

• Less than 24 hours of admission to the PICU

• Parent/LAR consents for infant to participate

Exclusion Criteria:

• Patients with the following conditions are ineligible: chronic lung disease, unrepaired congenital heart disease, and cyanotic heart disease.